Canada Pension Plan Investment Board’s Syndax Pharmaceuticals SNDX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-229,600	Closed	-$5.36M	–	1853
2026 Q1	$5.36M	Hold	229,600	–	–	﹤0.01%	752
2025 Q4	$4.82M	Hold	229,600	–	–	﹤0.01%	787
2025 Q3	$3.53M	Buy	+229,600	New	+$3.01M	﹤0.01%	814
2025 Q1	–	Sell	-70,000	Closed	-$925K	–	1468
2024 Q4	$925K	Hold	70,000	–	–	﹤0.01%	1032
2024 Q3	$1.35M	Buy	+70,000	New	+$1.45M	﹤0.01%	942

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Canada Pension Plan Investment Board's SNDX Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Syndax Pharmaceuticals (SNDX) in Q2 2026, closing a stake of 229,600 shares — an estimated $5.36M sold.

Canada Pension Plan Investment Board first reported a position in SNDX in Q3 2024 and held it in 5 quarters. The position peaked at $5.36M in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Canada Pension Plan Investment Board reported no remaining Syndax Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Canada Pension Plan Investment Board sold 229,600 Syndax Pharmaceuticals shares in Q2 2026, an estimated $5.36M.
Canada Pension Plan Investment Board first reported a position in Syndax Pharmaceuticals in Q3 2024 and held it in 5 quarters.
Canada Pension Plan Investment Board's Syndax Pharmaceuticals position peaked at $5.36M in Q1 2026.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.